Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
BOLD compared with LYEL: revenue, margins and what each company keeps, and the suppliers and customers both name
BOLD
Boundless Bio, Inc.
Change
Mkt cap
Revenue
Revenue
LYEL
Lyell Immunopharma, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
BOLD
Boundless Bio, Inc.
vs
LYEL
Lyell Immunopharma, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
BOLD
Boundless Bio, Inc.
Change
2.45
▼
−1.21%
· post 2.45
Mkt cap
$56.2M
Revenue
—
Revenue
—
LYEL
Lyell Immunopharma, Inc.
Change
10.96
▼
−3.03%
· post 10.96
Closed
Oct 30 '26
Mkt cap
$270.5M
Revenue
$4,000
Q2 FY26
Revenue
$36,000
FY25
vs
Compare
Closed
Oct 30 '26
BOLD
Boundless Bio, Inc.
vs
LYEL
Lyell Immunopharma, Inc.
2.45
▼
−1.21%
post 2.45
Price
10.96
▼
−3.03%
post 10.96
$56.2M
Mkt cap
$270.5M
—
Revenue
$4,000
Q2 FY26
—
Revenue
$36,000
FY25
Change
Change
BOLD
2.45
▼
−1.21%
vs
LYEL
10.96
▼
−3.03%
Closed
Oct 30 '26
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
BOLD, solid
LYEL, dashed
Supply-chain overlap
Revenue flow
BOLD: latest quarter not drawable. LYEL: latest quarter is a loss; flow not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only BOLD
0
None
Shared
0
No disclosed counterparties: BOLD.
Only LYEL
11
—
City of Hope Comprehensive Cancer Center
unlisted
supplier
—
Dana Farber Cancer Institute
unlisted
supplier
—
Innovative Cellular Therapeutics Holdings Limited and Innovative Cellular Therapeutics, Inc. (together, ICT)
unlisted
supplier
—
Miltenyi CliniMACS PRODIGY ®
unlisted
supplier
7 more · LYEL chain
›
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR